EVISA Glossary on | Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).

Supporters of EVISA includes:


Official Journal of the American Cancer Society


Biological Abstracts® (Thomson ISI), BIOSIS Previews® (Thomson ISI), CAB Abstracts® (CABI), Cambridge Scientific Abstracts (CSA/CIG), Chemical Abstracts Service/SciFinder (ACS), CINAHL: Cumulative Index to Nursing & Allied Health Literature (EBSCO), CSA Biological Sciences Database (CSA/CIG), Current Awareness in Biological Sciences (Elsevier), Current Contents®/Clinical Medicine (Thomson ISI), Current Contents®/Life Sciences (Thomson ISI), Current Index to Statistics (ASA/IMS), EMBASE/Excerpta Medica (Elsevier), EORTC Database (European Organisation for Research and Treatment of Cancer), Index Medicus/MEDLINE/PubMed (NLM), Journal Citation Reports/Science Edition (Thomson ISI), PASCAL Database (INIST/CNRS), Psychological Abstracts/PsycINFO (APA), Reference Update (Thomson ISI), Science Citation Index Expanded™ (Thomson ISI), Science Citation Index® (Thomson ISI), SCOPUS (Elsevier), SIIC Databases (Sociedad Iberoamericana de Informacion Cientifica), Web of Science® (Thomson ISI)

Source type
First volume
Last volume

CANCER is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of CANCER is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology and course of human cancer. CANCER accomplishes this objective by publishing original articles, as well as other scientific and educational documents, that support the mission of the American Cancer Society by facilitating the transfer of knowledge from the laboratory to the bedside; contributing to cancer prevention, early detection, diagnosis, cure, and rehabilitation; and diminishing suffering from cancer.

CANCER is pleased to receive original articles related to human cancer including, but not limited to: biologic response modifiers (such as growth factors, interferons, interleukins, lymphotoxins), clinical observations, chemotherapy, clinical trials, detection, epidemiology, ethical issues, etiology, genetics and cytogenetics, imaging, immunology and immunotherapy, oncogenes, pathology and clinicopathologic correlations, prevention, psychosocial studies, radiation therapy, screening, staging, and surgical therapy.

In addition to Original Articles, CANCER publishes other categories including Tributes, solicited Editorials, Commentaries, Review Articles, and Correspondence. Tributes highlight the accomplishments of distinguished individuals for their contributions to oncology. A solicited Editorial relates to a manuscript in the same issue or a topic of current interest. A Commentary presents a point of view of general interest. A Review Article must be a timely, in-depth treatment of an issue. Correspondence referring to a manuscript published in CANCER within the previous six months may be considered, and, if considered, the authors of the original publication will be given the opportunity to respond. Case Reports are not encouraged and are considered only if justified by their unique significance. Titles of single case reports must have the subheading: "A Case Report". The final decision on publication of a manuscript rests with the Editorial Board and ultimately with the Editor-in-Chief. All papers, regardless of type, represent the opinion of the authors and not necessarily that of the American Cancer Society, the Editors, or the Publisher.

The journal groups publications in the table of contents within the following categories: (1) Tribute; (2) Editorial; (3) Commentary; (4) Review Article; (5) Original Article by (a) anatomic site or (b) general topic (not limited to a specific anatomic site, e.g., Kaposi's sarcoma); and (6) Correspondence. Special categories may be introduced for papers on selected topics (e.g., Communications from organizations such as the American Cancer Society, the Commission on Cancer of the American College of Surgeons, American Joint Committee on Cancer, or from individuals relevant to a timely issue, but not related to a manuscript in the current issue, which would be an Editorial).

Imprint     Disclaimer

© 2003 - 2024 by European Virtual Institute for Speciation Analysis ( EVISA )